DOI: 10.1016/j.jval.2012.08.1197 View full text |Buy / Rent full text

Abstract: OBJECTIVES: Radiation-induced nausea and vomiting (RINV) is commonly experienced by cancer patients undergoing radiation treatment. Current NCCN guidelines recommend the use of the 5-hydroxytryptamine-3 serotonin receptor antagonists (5-HT3-RAs) for the prevention and treatment of RINV. The purpose of this study was to examine the incidence of 5-HT3-RA utilization and subsequent RINV, in patients diagnosed with colon cancer and undergoing radiation treatment. METHODS: This was a retrospective analysis using HI… Show more

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles